HRS-9190

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for HRS-9190, covering 2025-11-28 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy Participants [Phase 1]